EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Obesity and heart failure: exploring the cardiometabolic axis

Jennifer J Rayner iD, Ines Abdesselam, Jiliu Pan, Andrew J M Lewis, Oliver J Rider

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Jennifer J Rayner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, …. Hauptthemen laut MEDLINE: Heart Failure, Obesity, Energy Metabolism. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation Clinical Research Training Fellowship, British Heart Foundation Intermediate Clinical Fellowship, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is one of the biggest risks to public health in both developed and developing countries, and yet incidence continues to skyrocket. Being the main risk factor for a large number of life-limiting conditions, obesity has the potential to cause enormous damage unless addressed urgently. Heart failure (HF) is the most common cardiovascular disease associated with obesity. The incidence of HF overall continues to rise and mortality rates remain high, despite the rapid and significant advances in pharmacotherapy that have recently transformed the landscape of HF treatment. Both obesity and heart failure are multisystem disorders that are closely interlinked. Obesity poses the body a number of challenges, ranging from haemodynamic, to neuroendocrine, to inflammatory, to intracellular physiology. This narrative review describes the pathophysiological ‘vicious cycle’ caused by the combination of obesity and HF. Management of obesity in established heart failure has for years been a controversial topic, and yet an increasing body of evidence suggests that there are numerous benefits to managing obesity and insulin resistance in heart failure. Here, we review the existing evidence base, as well as exciting new developments, suggesting that we may finally be on the brink of a revolution in managing obesity in heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureObesityEnergy MetabolismHumansAnimalsInsulin ResistanceAnti-Obesity AgentsPrognosisHemodynamicsSignal TransductionCardiometabolic Risk FactorsRisk Factors

Stichwörter der Autor:innen

Heart failureMetabolic syndromeObesityWeight loss

Substanzen

Anti-Obesity Agents

Autor:innen und Institutionen

  • Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.

ORCID-Profile: Jennifer J Rayner

Förderung

  • British Heart Foundation Clinical Research Training Fellowship
  • British Heart Foundation Intermediate Clinical Fellowship
  • British Heart Foundation

Zitieren

APA

Rayner, J. J., Abdesselam, I., Pan, J., Lewis, A. J. M., & Rider, O. J. (2025). Obesity and heart failure: exploring the cardiometabolic axis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf090

Vancouver

Rayner JJ, Abdesselam I, Pan J, Lewis AJM, Rider OJ. Obesity and heart failure: exploring the cardiometabolic axis. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf090

BibTeX
@article{Rayner2025,
  author = {Rayner, Jennifer J and Abdesselam, Ines and Pan, Jiliu and Lewis, Andrew J M and Rider, Oliver J},
  title = {Obesity and heart failure: exploring the cardiometabolic axis},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf090}
}
Kostenlos starten →